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EDITORIAL POLICIES
SCOPE OF THE JOURNAL
The Journal of Vascular Surgery is dedicated to the
science and art of vascular surgery and aims to improve
the management of patients with vascular diseases by
publishing relevant papers that report important med-
ical advances, test new hypotheses, and address current
controversies. To achieve this goal, the Journal will pub-
lish original clinical and laboratory studies and reports
and papers that comment on the social, economic, eth-
ical, legal, and political factors that relate to these aims.
PEER REVIEW
Principles of peer review
Objectives. The purpose of peer review is to help
ensure that the published papers are of the highest qual-
ity by (1) advising the editors on the originality of the
work, its importance relative to what has already been
published in the current literature, its relevance to the
objectives of the Journal, its scientific creditability, and
its acceptability for publication, given the space that is
available; and (2) by suggesting changes and providing
advice and assistance to the authors on important
aspects that may improve their manuscript.
Fairness. The success of peer review requires that all
reviewers exercise careful scientific judgment, be impar-
tial and equitable, and form a balanced view of the con-
tent of each manuscript. There is no formula that can
guide the reviewers in this task, apart from the require-
ment to be objective and fair.
Confidentiality. All documents and information
provided for the purpose of peer review must be kept
entirely confidential. Unauthorized access to papers
must be prevented by storing them in a secure manner.
The documents must not be shared with other col-
leagues. If a reviewer wishes to seek a colleague’s opin-
ion on the scientific merit of a manuscript, the Editors
must be consulted first, and the colleague must adhere
to the same standards of confidentiality.
The manuscript must not be photocopied. When the
review is completed, the documents must be destroyed
or returned to the Journal office.
Any inquiries received by individual reviewers about
a manuscript should be referred to the Editors.
Conflict of interest. The decisions of the Editors
must be fair and objective and they must be seen to be
impartial. Because the final decision on publication rests
with the Editors, their decisions must not be influenced
by the Joint Council of The Society for Vascular Surgery
and the American Association for Vascular Surgery, the
affiliated vascular societies, or representatives of compa-
nies, advertisers, government, or others who might have
conflicts of interest.
Reviewers must decline to review any manuscript
applications with which they may have a conflict of
interest and should avoid reviewing any manuscript if
circumstances exist that could be viewed as affecting
their impartiality. For example, a reviewer should not
review a manuscript submitted by a close personal
friend, individuals from his or her institution, individu-
als with whom the reviewer has collaborated, or a sci-
entist with whom the reviewer has had long-standing
scientific or personal differences. When the reviewer is
uncertain as to whether a conflict exists, he or she
should inform the Editor of the circumstances and the
Editor will make the final decision.
The peer review process. Fewer than half of the
manuscripts received by the Journal can be published.
The editors and reviewers, by providing prompt and
authoritative review, aim to optimize the quality of the
published papers.
All submitted manuscripts are reviewed initially by
the Editor-in-Chief, Senior Editor, and/or an Associate
Editor. A submission may be rejected outright if at least
two of the Editors conclude that it does not have suffi-
cient merit to warrant publication.
Other manuscripts will be sent to two or three mem-
bers of the editorial board or to other expert consultants
for external peer review. The identities of these review-
ers are kept confidential. Reviewers are asked to give the
editors a confidential opinion on the importance, origi-
nality, and scientific merit of the manuscript; rank its
importance relative to what has already been published
in the medical literature; and suggest changes that will
improve the paper.
A formal statistical review may be obtained to ensure
that the study population was clearly defined, that the
design of the study was suitable, that appropriate statis-
tical methods were used, and that the subsequent con-
clusions were supported by the data and their analysis.
If two manuscripts are received on the same subject,
unless both can be accommodated in the Journal, prior-
ity in the review process will be given to the manuscript
that was submitted first as determined by the postmark.
The editor will promptly contact the authors of the sec-
ond manuscript to inform them of the problem and give
them the option of submitting their manuscript to
another journal.
Administrative issues related to peer review.
Authors are expected to comply with the published
Information for Authors. The Journal’s requirements
for submission of a manuscript are in accordance with
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the “Uniform Requirements for a Manuscript
Submitted to Biomedical Journals” published in JAMA
1997;277:927-34. Failure to adhere to these guidelines
may negatively influence the opinions of the editors and
reviewers, and thus the manuscript may be returned to
the author for appropriate revisions in organization
before it is sent out for peer review.
The editors will convey the final decision on the dis-
position of the manuscript to the designated correspond-
ing author along with the reasons for the decision and the
complete or summarized comments from the reviewers.
If revisions are requested, the editor expects the authors
to revise the manuscript appropriately and promptly to
meet publication deadlines. The authors must clearly indi-
cate the changes that have been made and/or explain their
difference of opinion with the reviewers.
At the completion of the peer review process, the
copies of the submitted manuscript will not be returned
to the authors. If the paper is rejected, the figures will
be returned only on request.
The editors will send the reviewers a notification of
their final decision on the disposition of a manuscript
and, when appropriate to the review process, the com-
ments of other reviewers.
All manuscripts and correspondence will be kept
on file for a reasonable period of time before being
destroyed so that questions that may arise can be
answered.
TRANSFER OF COPYRIGHT OWNERSHIP TO
THE JOURNAL
Before a manuscript can be reviewed and published,
the authors must provide a signed agreement transfer-
ring, assigning, or conveying all copyright ownership of
their manuscript to The Society for Vascular Surgery
and the American Association for Vascular Surgery.
Hence, manuscripts accepted for publication become
the permanent property of the societies and may not be
published elsewhere by the authors without written
permission from the Journal. The authors must sign the
following statement. “The undersigned author(s)
transfer(s), assign(s), or otherwise convey(s) all copy-
right ownership of the manuscript to The Society for
Vascular Surgery and the American Association for
Vascular Surgery, in the event the work or a revised ver-
sion is published in the Journal of Vascular Surgery.” If
the work is not accepted by the Journal, this agreement
becomes null and void.
Manuscripts written by employees of the federal gov-
ernment during the course of their official duties may
not be copyrightable. A separate attached letter should
explain this circumstance.
Subsequent to acceptance for publication, if the
authors withdraw their manuscript, the Journal may
make appropriate charges to cover the production
costs incurred.
Copies of the copyright document will be kept
indefinitely.
An individual may make a single photocopy of a
paper for his or her personal use, but multiple copies
cannot be made without the written permission of the
Journal or from the Copyright Clearance Center.
ORIGINALITY OF MANUSCRIPT
The authors must certify that their article is original,
has not been published previously, and is not under con-
sideration for publication by another journal.The
authors must sign the following statement. “The under-
signed author(s) warrant(s) that the article is original in
form and substance, a manuscript of similar content has
not been published in print or digital medium under my
(our) authorship, does not infringe upon any copyright
or other proprietary right of any third party, and is not
under consideration by another journal.”
Previous presentations and abstracts. If the work
has been presented previously at a meeting as an oral
presentation or poster or has been published in an
abstract, a detailed report will be considered for publi-
cation. However, the authors are expected to submit the
details of the previous presentations and provide the
abstracts. In general, manuscripts will not be considered
if the work had been published previously in full-length
conference proceedings or as a book chapter.
Major update of a previous study. If the submitted
manuscript is a major update on the results of a previ-
ously published study, the authors must submit copies
of the previous papers so that the editors can determine
whether the new paper provides significant new infor-
mation or statistical power to warrant publication.
Media releases. The editors recognize that news
organizations have the right to disseminate information
that may have been obtained from a presentation at a
scientific meeting or through direct discussions with the
author. It is the author’s responsibility to inform the
editors that the work has been reported previously by a
journalist and explain the circumstances. In doing so,
the authors should supply the editors with the original
media report.
If the results of the study may potentially have a
major impact on patient management, the authors can
request the Editor’s consideration of prompt review
and publication.
Once submitted to the Journal, discussion of the
contents of a manuscript with the media must be
delayed until the publication date of the paper unless
the editors provide prior approval. If the authors pro-
vide additional information to the media during the
peer-review or publication process, the article may be
rejected or withdrawn from publication.
In some instances, the editors may ask the authors to
prepare a brief press release summarizing the manu-
script. However, as with all papers, further discussion of
JOURNAL OF VASCULAR SURGERY/January 2001   35A
the results with the media must be deferred until the
date of publication.
Multiple publication. A joint publication or sec-
ondary publication of a full-length paper in another
journal may be considered if the manuscript contains
important information that deserves to be disseminated
to a significantly different readership than that of the
Journal. The editors of the Journal may grant permis-
sion for secondary publication in another journal if the
original report in the Journal is appropriately acknowl-
edged and the secondary publication follows the initial
publication in the Journal. Abstracts or full-length sum-
maries of papers presented at meetings may be pub-
lished simultaneously in another journal with permis-
sion of the editors of both journals providing an
appropriate acknowledgment is made in each journal.
AUTHORSHIP
It is not appropriate to include an individual as an
author unless he or she has made a significant contribu-
tion to the conception or completion of the manuscript
and is willing to share the responsibility for the content
of the paper. Specifically, each of the authors should
have made a direct and substantial contribution to the
following areas: (1) conceiving and designing the study
and/or analyzing and interpreting the data; (2) writing
the manuscript or providing critical revisions that are
important for the intellectual content; and (3) approv-
ing the final version of the manuscript.
Each of the authors will be expected to sign an
authorship statement as follows. “The undersigned
author(s) certifies (certify) that I (we) have made a
direct and substantial contribution to the work report-
ed in the manuscript by participating in the following
areas: conceiving and designing the study and/or ana-
lyzing and interpreting the data; writing the manuscript
or providing critical revisions that are important for the
intellectual content; and approving the final version of
the manuscript. I (we) have participated to a sufficient
degree to take public responsibility for the work and
believe the manuscript describes truthful facts.”
If an author has collaborated in a project but does
not meet all the requirements for authorship, he or she
should be recognized in the acknowledgment section of
the manuscript.
The order of the authors’ names is at the discretion of
the coauthors, who may wish to add a footnote explain-
ing the order of authorship and/or their contributions.
ORIGINAL DATA
The authors must be prepared to provide their orig-
inal data for review by the editors and/or reviewers if
requested. Each author must sign the following state-
ment. “I (we) declare that I (we) shall produce the data
on which the manuscript is based for examination by the
editors or their assignees, should they request it.”
The authors are responsible for keeping their original
data and experimental notes on file for a reasonable
period of time in case a question should arise about the
manuscript after it has been published.
The authors should consider including a footnote in
the manuscript indicating their willingness to make the
original data available to other investigators through
electronic media to permit alternative analysis and/or
inclusion in meta-analysis.
AUTHORS’S DISCLOSURE OF COMPETITIVE
INTERESTS
The authors’ university, institutional, and/or corpo-
rate affiliations will be acknowledged on the title page
along with sources of funding. In addition, the Journal
expects the authors to disclose any commercial associa-
tions that might represent a conflict of interest in
respect to the manuscript.If a company’s product is
mentioned in a manuscript or other articles, including
letters to the editor and editorials, all authors are expect-
ed to declare whether they have a consulting or employ-
ment arrangement or a royalty or stock agreement with
the company. The authors must sign the following
statement. “I (we) do not have any paid or unpaid con-
sulting, employment, royalty, stock, patent agreement,
position or other financial relationship with any individ-
ual, company, organization with a vested interest in the
subject matter mentioned in the manuscript except as
disclosed below in an attached statement.”
During the review process, this relationship will be
held in confidence.
For articles accepted beginning July 1, 1999, a com-
petition of interest statement will be published with
each paper (Johnston KW Rutherford RB. Disclosure of
competition of interest JVS 30:200-2, 1999). If a paper
is accepted for publication, the authors will be asked to
clarify and update their competitive interest statements. 
Failure to disclose a conflict of interest will be dealt
with according to the following which has been pub-
lished in the Journal. (Johnston KW Rutherford RB.
Failure to disclose competitive interest. JVS 31:1306,
2000) “If it is brought to the editors’ attention that an
author may have failed to make an appropriate disclo-
sure, the editors will give the author the opportunity to
explain. If a satisfactory explanation is not forthcoming,
the editors will bring the issue to the attention of the
author’s institution for clarification. If the oversight can
be explained as an honest mistake, . . . a simple notation
of the error will be published. If there was either self-
deception or a deliberate attempt to conceal a signifi-
cant financial competitive interest, the editors will con-
clude that this may represent an attempt to deceive and
may be a violation of public and professional trust. The
editors will publish a notation that the paper may be
unreliable because the author did not meet the stan-
dards of honest disclosure of competitive interests
required by the Journal.”
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ETHICAL AND ANIMAL EXPERIMENTATION
APPROVAL
Human subjects. Manuscripts that involve research
conducted on human subjects must include a statement in
the Methods section that the experimental protocol and
informed consent were approved by the Institutional
Review Board and that all subjects gave informed consent.
The editors reserve the right to reject a manuscript if the
authors fail to make these statements in the manuscript or
if, at the request of the Editor, they do not provide appro-
priate documentation that their studies had appropriate
approval by their Institutional Review Board and that
informed consent was obtained from each patient.
Animal experiments. Manuscripts that report animal
experiments must include a statement in the Methods
section that the study was approved by the Institutional
Review Board and that the animal care complied with the
Guide for the Care and Use of Laboratory Animals,
Institute of Laboratory Animal Resources, Commission
on Life Sciences, National Research Council.
Washington: National Academy Press, 1996. [http://
stills.nap.edu/readingroom/books/labrats/]
CONSENT TO REPRODUCE PREVIOUSLY
PUBLISHED DATA
It is the authors’ responsibility to obtain written con-
sent from the copyright owner and the original author
to reproduce direct quotations, tables, or illustrations
that have appeared in copyrighted material and to pro-
vide complete information regarding their source.
Similarly, permission must be obtained for tables and
figures that have been modified from other publications.
PATIENT CONSENT FOR REPRODUCING
PHOTOGRAPHS AND CASE HISTORIES
Photographs of identifiable persons must be accom-
panied by signed releases from patients or from both liv-
ing parents or guardians of minors.Similarly, consent
must be obtained if a person can be identified from the
case description.
COPYEDITING
A manuscript that is accepted for publication is
subject to copyediting so that it will conform to the
Journal’s standards and style. The revised manuscript
will be returned to the authors for approval. By
approving the changes, the authors accept the respon-
sibility for the changes made in their manuscript by
the copy editor.
SEQUENCE OF PUBLICATION
In general, manuscripts are published in the order
they are received, providing that the Journal receives
revisions in a timely fashion. Also, subject to the same
limitations, every effort is made to publish the man-
uscripts presented at the annual meeting of The
Society for Vascular Surgery and The American
Association for Vascular Surgery and from the affili-
ated societies as a group.Under unusual circum-
stances, a paper may be assigned priority for early
publication if, in the view of the Editors, it contains
important new information that should be brought
to the attention of the readers immediately.
PUBLISHED DISCUSSIONS
The discussions of papers presented at The Society
for Vascular Surgery and the American Association for
Vascular Surgery and at some of the meetings of the
affiliated societies will be published with the manu-
scripts; however, these discussions are subject to edito-
rial review and only those that enhance the text or pre-
sent alternative views will be published.
SCIENTIFIC MISCONDUCT
Misconduct in science was defined by the National
Academy of Sciences, National Academy of Engineering,
and the Institute of Medicine in 1992 as fabrication (ie,
making up) of data or results, falsification (ie, changing)
of data or results, or plagiarism (ie, unauthorized use of
the words, data, or ideas of another person without giv-
ing appropriate credit) in proposing, performing, or
reporting research. Misconduct in science does not
include errors in the scientific method or in experimental
design or data interpretation.In dealing with alleged sci-
entific misconduct, the appropriate steps in the process
include informing the authors of the allegations, request-
ing clarification, determining whether the misconduct did
or did not occur, and, to the extent possible, establishing
the intent, ascertaining whether there were mitigating
factors, and making recommendations for appropriate
action.If a charge of scientific misconduct appears to be
justified, it is the editors’ responsibility to refer the matter
to the appropriate individual at the authors’ university or
institution where the work was done.
The university or institution has the responsibility to
investigate alleged scientific misconduct.
If the charge of scientific misconduct is substantiated,
the Journal will print a retraction and may impose sanc-
tions that could include a restriction on future publica-
tion in the Journal. The decision to issue a retraction
generally must be made by the authors and/or the
appropriate authorities at the university or institution
who have access to the full details of the investigation. A
published retraction will include the title of the original
article, the same first author as in the original paper, the
reasons why the article is being retracted, the circum-
stances of the case, and a bibliographic reference to the
original paper. The retraction will be listed under a sep-
arate heading in the Table of Contents.
CORRECTION OF ERRORS
As part of scientific process, errors may be discovered
after publication that require clarification, correction, or
retraction of the paper. The editor will handle errors on
an individual basis after discussion with the authors.
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